These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 17666870)
1. [Molecular mechanism of neuroprotective drugs against oxidative stress-induced neuronal cell death]. Hara H Yakugaku Zasshi; 2007 Aug; 127(8):1199-205. PubMed ID: 17666870 [TBL] [Abstract][Full Text] [Related]
2. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. Hara H; Ohta M; Adachi T J Neurosci Res; 2006 Sep; 84(4):860-6. PubMed ID: 16802348 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5,7-Dihydroxychromone: Activation of the Nrf2/ARE pathway. Kim DW; Lee KT; Kwon J; Lee HJ; Lee D; Mar W Life Sci; 2015 Jun; 130():25-30. PubMed ID: 25818191 [TBL] [Abstract][Full Text] [Related]
4. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. Kraft AD; Johnson DA; Johnson JA J Neurosci; 2004 Feb; 24(5):1101-12. PubMed ID: 14762128 [TBL] [Abstract][Full Text] [Related]
5. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death. Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546 [TBL] [Abstract][Full Text] [Related]
6. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. Mann GE; Niehueser-Saran J; Watson A; Gao L; Ishii T; de Winter P; Siow RC Sheng Li Xue Bao; 2007 Apr; 59(2):117-27. PubMed ID: 17437032 [TBL] [Abstract][Full Text] [Related]
7. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. Satoh T; Okamoto SI; Cui J; Watanabe Y; Furuta K; Suzuki M; Tohyama K; Lipton SA Proc Natl Acad Sci U S A; 2006 Jan; 103(3):768-73. PubMed ID: 16407140 [TBL] [Abstract][Full Text] [Related]
8. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders. van Muiswinkel FL; Kuiperij HB Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029 [TBL] [Abstract][Full Text] [Related]
9. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways. Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537 [TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway. Zhang XS; Ha S; Wang XL; Shi YL; Duan SS; Li ZA Neuroscience; 2015 Sep; 303():489-502. PubMed ID: 26116522 [TBL] [Abstract][Full Text] [Related]
11. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424 [TBL] [Abstract][Full Text] [Related]
12. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway. Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline. Koriyama Y; Nakayama Y; Matsugo S; Kato S Brain Res; 2013 Mar; 1499():145-57. PubMed ID: 23295186 [TBL] [Abstract][Full Text] [Related]
14. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases. Zgorzynska E; Dziedzic B; Walczewska A Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501 [TBL] [Abstract][Full Text] [Related]
15. Apomorphine, a dopamine receptor agonist with remarkable antioxidant and cytoprotective properties. Gassen M; Gross A; Youdim MB Adv Neurol; 1999; 80():297-302. PubMed ID: 10410734 [No Abstract] [Full Text] [Related]
16. Dual neuroprotective pathways of a pro-electrophilic compound via HSF-1-activated heat-shock proteins and Nrf2-activated phase 2 antioxidant response enzymes. Satoh T; Rezaie T; Seki M; Sunico CR; Tabuchi T; Kitagawa T; Yanagitai M; Senzaki M; Kosegawa C; Taira H; McKercher SR; Hoffman JK; Roth GP; Lipton SA J Neurochem; 2011 Nov; 119(3):569-78. PubMed ID: 21883218 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2. Jing X; Wei X; Ren M; Wang L; Zhang X; Lou H Neurochem Res; 2016 Apr; 41(4):779-86. PubMed ID: 26537816 [TBL] [Abstract][Full Text] [Related]
18. The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Joshi G; Johnson JA Recent Pat CNS Drug Discov; 2012 Dec; 7(3):218-29. PubMed ID: 22742419 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes. Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917 [TBL] [Abstract][Full Text] [Related]
20. Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell death. Kumar H; Koppula S; Kim IS; More SV; Kim BW; Choi DK CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1015-29. PubMed ID: 23244425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]